Cereno Scientific presents at ABGSC Investor Days, May 23
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, is scheduled to present at the ABGSC Investor Days in Stockholm on May 23, 2024, at 15:15. CEO Sten R. Sörensen will present the Company’s pipeline and meet with potential investors.Read more about the Investor Days on the ABGSC website here . For further information, please contact: Henrik Westdahl, Director IR & Communications Email: henrik.westdahl@